Mountain Crest Acquisition Corp. (MCACU), the latest SPAC to file for IPO, debuted a $50 million deal that has a unit with just one share and one right (1/10), but without any warrants. However, Mountain Crest IS offering an over-funded trust at $10.20 day one. It’s a bit curious to remove warrants in an environment where other SPACs are increasing their warrant coverage in order to sell. So will this structure work?
Not including a warrant in a SPAC unit is unusual, but not unheard of. Atlantic Acquisition Corp., which is now HFFG, had a similar structure and was also underwritten by Chardan. Atlantic was also over funded at $10.20 with one share and one right, but was a $40 million IPO versus Mountain Crests $50 million. However, the big advantage in not having any warrants associated with a SPAC is in negotiation with a target company. They get to start day-one as a public company without a public SPAC warrant overhang and the rights convert to shares at closing. It’s a much cleaner structure. However, in light of the absence of warrants, Mountain is over-funding at $10.20 in trust at day-one of IPO.
Additionally, Mountain Crest intends to focus on companies in North America and will be led by Dr. Suying Liu, as Chairman and CEO. Dr. Liu has been the Head of Corporate Strategy of Hudson Capital Inc. (Nasdaq: HUSN) since May 2020, where he leads the company’s strategic development for both general operations and specific growth areas. And while May of 2020 is fairly recent, between November 2018 and April 2020, Dr. Liu served as the Chief Strategist of Mansion Capital LLC, a privately-held real estate investment firm with brokerage and property management operations serving clients from both North America and Asia for their investments in the U.S. real estate market.
Looking at the rest of Mountain Crest’s structure, this SPAC has 12 months to close a combination, but can extend three times, for 3-months each, by contributing $0.10 per share to trust, or 21 months total. There is no Crescent Term included because there aren’t any warrants. However, Mountain Crest is only trying to raise $50 million and it’s a lot easier to get to $50 million than it is to $200 million or $300 million. So this will be another interesting test case…maybe $10.20 is attractive enough to generate interest. We’ll have to wait and see.
Summary of terms below:
SPACInsider 2024 Awards 2024 was clearly a rebuilding year for SPACs and the pace didn’t really gather momentum until June. But in typical SPAC fashion, once the market catches fire, it builds very, very quickly. With that being said, there are some noteworthy standouts this year that are worth highlighting. As such, this is the...
At the SPAC of Dawn (UPDATED) It was a slow start to the day after the Christmas holiday, especially because the SEC was “experiencing technical difficulties” this morning. That makes for a slow news day. Other than that, we hope everyone had a great holiday and is easing back into the work flow. Deals and...
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...